SmartBayt Professionel

Primær information

  • Handelsnavn:
  • SmartBayt Professionel Sneglekorn
  • Lægemiddelform:
  • Sneglekorn
  • Sammensætning:
  • 16,2 g/kg jern(III)fosfat
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

Lokation

  • Fås i:
  • SmartBayt Professionel Sneglekorn
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Ikke længere markedsført
  • Autorisationsnummer:
  • 18-525
  • Sidste ændring:
  • 26-02-2018

Indlægsseddel

20-3-2018

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy

FDA approves Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy

FDA - U.S. Food and Drug Administration

28-9-2017

Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use

Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use

Type III endoleak may require treatment with additional interventions such as re-lining, insertion of additional endograft components, or open surgical repair. Interventions to address endoleaks carry added risks for impacted patients.

FDA - U.S. Food and Drug Administration

28-9-2017

#FDA issues letter to health care providers RE: risk of Type III endoleaks associated with Endovascular Grafts!  https://go.usa.gov/xRh6K 

#FDA issues letter to health care providers RE: risk of Type III endoleaks associated with Endovascular Grafts! https://go.usa.gov/xRh6K 

#FDA issues letter to health care providers RE: risk of Type III endoleaks associated with Endovascular Grafts! https://go.usa.gov/xRh6K 

FDA - U.S. Food and Drug Administration